APA

Lickliter J. D., Francesconi A. B., Smith G., Burge M., Coulthard A., Rose S., Griffin M., Milne R., McCarron J., Yeadon T., Wilks A., Cubitt A., Wyld D. K. & Vasey P. A. (20100910). Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent. : British journal of cancer.

Chicago

Lickliter J D, Francesconi A B, Smith G, Burge M, Coulthard A, Rose S, Griffin M, Milne R, McCarron J, Yeadon T, Wilks A, Cubitt A, Wyld D K and Vasey P A. 20100910. Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent. : British journal of cancer.

Harvard

Lickliter J. D., Francesconi A. B., Smith G., Burge M., Coulthard A., Rose S., Griffin M., Milne R., McCarron J., Yeadon T., Wilks A., Cubitt A., Wyld D. K. and Vasey P. A. (20100910). Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent. : British journal of cancer.

MLA

Lickliter J D, Francesconi A B, Smith G, Burge M, Coulthard A, Rose S, Griffin M, Milne R, McCarron J, Yeadon T, Wilks A, Cubitt A, Wyld D K and Vasey P A. Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent. : British journal of cancer. 20100910.